Understanding Lab Tests for Hepatocellular carcinoma
Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. While definitive diagnosis typically requires imaging studies and tissue biopsy, blood tests play a crucial role in screening, risk assessment, and monitoring for this serious condition.
Top Recommended Test
Alpha-Fetoprotein (AFP), Serum, Tumor Marker
AFP is a key tumor marker that is often elevated in cases of hepatocellular carcinoma. High AFP levels can be indicative of the presence of liver tumors and are widely used for screening high-risk patients and monitoring treatment response in those diagnosed with HCC.
2907 reviews
The Role of Blood Testing in Hepatocellular Carcinoma
Blood tests are fundamental tools in the evaluation of hepatocellular carcinoma. They help identify tumor markers that may indicate the presence of cancer, assess risk factors such as chronic viral infections, and monitor patients at high risk for developing HCC. These tests provide valuable information that guides further diagnostic evaluation and treatment decisions.
Other Relevant Tests
Hep B Core Antibody, IgM
This test helps identify chronic Hepatitis B infection, which significantly increases the risk of developing hepatocellular carcinoma. Patients with chronic Hepatitis B require regular surveillance for liver cancer, making this test essential for risk stratification and screening programs.
2907 reviews
Understanding Your Test Results
Elevated AFP levels may suggest the presence of hepatocellular carcinoma, though levels can also be raised in other liver conditions. Positive hepatitis B markers indicate chronic infection and the need for enhanced liver cancer surveillance. It's important to note that these blood tests are screening and monitoring tools that work alongside imaging studies and clinical evaluation for comprehensive assessment.
Important Considerations
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment. Early detection through appropriate screening can significantly impact treatment outcomes for hepatocellular carcinoma.
